ストックスクリーナーアプリを入手
133.66
5.18%
-7.30
アフターアワーズ：
134.40
0.74
+0.55%
前日終値:
$140.96
開ける：
$140.41
24時間の取引高:
1.51M
Relative Volume:
1.16
時価総額：
$18.25B
収益：
$1.53B
当期純損益:
$-214.69M
株価収益率:
-75.94
EPS:
-1.76
ネットキャッシュフロー:
$-43.68M
1週間 パフォーマンス:
-5.25%
1か月 パフォーマンス:
-20.88%
6か月 パフォーマンス:
-24.45%
1年 パフォーマンス:
+30.54%
1日の値動き範囲:
$133.23
$140.41
1週間の範囲:
$133.23
$143.36
52週間の値動き範囲:
$92.14
$183.00
Natera Inc Stock (NTRA) Company Profile
NTRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
133.66 | 19.25B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Natera to Report Its Second Quarter Results on August 7, 2025 - Yahoo Finance
Evercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating - MSN
SEC Filings Archive 2025-07-30Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera: president Fesko sells $239k in shares - Investing.com Australia
Natera executive chairman Rabinowitz sells $240k in stock - Investing.com Australia
Natera executive chairman Rabinowitz sells $240k in stock By Investing.com - Investing.com Nigeria
Natera CEO Steven Chapman sells $852k in shares By Investing.com - Investing.com Canada
Natera CFO Brophy sells $700k in shares - Investing.com
Natera Executives and Director Sell Shares to Cover Tax Obligations - TradingView
Natera initiates trial of Signatera test for breast cancer - Yahoo Finance
10 High Growth Stocks Outside Tech Analysts Are Bullish On - Insider Monkey
Natera Announces Launch of ABCSG 61 (“TEODOR”), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer - BioSpace
Elliott Wave Theory Predicts Pullback in Natera Inc.Low Risk High Return Opportunities Identified - metal.it
Analysts Backtest Strategies on Natera Inc. With Promising ResultsEntry Alert Based on Volume Spikes Detected - metal.it
RBC Capital Maintains a Buy on Natera (NTRA) With a $251 PT - MSN
Natera launches TEODOR trial - TipRanks
Breakeven On The Horizon For Natera, Inc. (NASDAQ:NTRA) - simplywall.st
Natera Announces Launch of ABCSG 61 ("TEODOR"), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer - Yahoo Finance
Non-Invasive Prenatal Testing Market Forecast and Company - GlobeNewswire
Is Natera Inc. stock a good hedge against inflationProfit Target Stock Opportunity Monitor Activated - metal.it
NeoGenomics Wants Jury Trial In Natera DNA Test Patent Fight - Law360
JPMorgan Chase & Co. Increases Stake in Natera Inc. - GuruFocus
Judge trims Natera verdict, keeps ad ban and bulk of damages - Daily Journal
How does Natera Inc. compare to its industry peersBeginner Investor Review Backed By Experts - jammulinksnews.com
Does Natera Inc. stock perform well during market downturnsExplosive earning power - jammulinksnews.com
Evercore ISI initiates Natera stock with Outperform rating, $170 price target - Investing.com Australia
Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance
What is the dividend policy of Natera Inc. stockCapitalize on market trends before they peak - jammulinksnews.com
Genetic testing company opens patient service center in Cumberland County - PennLive.com
What is the risk reward ratio of investing in Natera Inc. stockDiscover stocks with explosive growth potential - jammulinksnews.com
How strong is Natera Inc. company’s balance sheetMaximize your portfolio’s growth with expert tips - jammulinksnews.com
What markets is Natera Inc. expanding into Is ATYR stock a good long term investment optionChart Pattern Recommendation For Smart Trading - jammulinksnews.com
What makes Natera Inc. stock price move sharplyProven Return Strategy Execution - metal.it
Published on: 2025-07-27 21:21:41 - jammulinksnews.com
Is Natera Inc. Stock a Smart Buy in 2025 Investment Analysis InsideStable Stocks With High Yield - metal.it
When is Natera Inc. stock expected to show significant growthRapid wealth creation - jammulinksnews.com
What are Natera Inc. company’s key revenue driversTremendous return rates - jammulinksnews.com
Natera Maintains Strong Buy Rating from Leerink Partners Amid Insider Selling - AInvest
10 Best Strong Buy Healthcare Stocks to Buy Now - Insider Monkey
What analysts say about Natera Inc. stockTriple-digit growth rates - PrintWeekIndia
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.
What institutions are buying Natera Inc. stock nowHigh-yield capital appreciation - jammulinksnews.com
Natera CFO Brophy sold $303k in NTRA stock By Investing.com - Investing.com India
Natera CFO Brophy sold $303k in NTRA stock - Investing.com
Natera's Prospera™ Heart with DQS: A Game-Changer in Transplant Monitoring - AInvest
PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT - Yahoo Finance
Natera(NTRA) Plunges 1.50% Amid Insider Sales - AInvest
Natera's Trading Volume Surges 62.2% to $257 Million, Ranks 440th Despite Stock Price Decline - AInvest
Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
Natera CEO Chapman sells $225,928 in shares By Investing.com - Investing.com India
Natera’s chief legal officer sells $3.4 million in stock - Investing.com Australia
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
大文字化:
|
ボリューム (24 時間):